Literature DB >> 36073342

Conserved age-related increases in hippocampal PDE11A4 cause unexpected proteinopathies and cognitive decline of social associative memories.

Katy Pilarzyk1, Latarsha Porcher1, William R Capell1, Steven D Burbano1, Jeff Davis2, Janet L Fisher1, Nicole Gorny3, Siena Petrolle3, Michy P Kelly1,3,4.   

Abstract

In humans, associative memories are more susceptible to age-related cognitive decline (ARCD) than are recognition memories. Reduced cAMP/cGMP signaling in the hippocampus may contribute to ARCD. Here, we found that both aging and traumatic brain injury-associated dementia increased the expression of the cAMP/cGMP-degrading enzyme phosphodiesterase 11A (PDE11A) in the human hippocampus. Further, age-related increases in hippocampal PDE11A4 mRNA and protein were conserved in mice, as was the increased vulnerability of associative versus recognition memories to ARCD. Interestingly, mouse PDE11A4 protein in the aged ventral hippocampus (VHIPP) ectopically accumulated in the membrane fraction and filamentous structures we term "ghost axons." These age-related increases in expression were driven by reduced exoribonuclease-mediated degradation of PDE11A mRNA and increased PDE11A4-pS117/pS124, the latter of which also drove the punctate accumulation of PDE11A4. In contrast, PDE11A4-pS162 caused dispersal. Importantly, preventing age-related increases in PDE11 expression via genetic deletion protected mice from ARCD of short-term and remote long-term associative memory (aLTM) in the social transmission of food preference assay, albeit at the expense of recent aLTM. Further, mimicking age-related overexpression of PDE11A4 in CA1 of old KO mice caused aging-like impairments in CREB function and remote social-but not non-social-LTMs. RNA sequencing and phosphoproteomic analyses of VHIPP identified cGMP-PKG-as opposed to cAMP-PKA-as well as circadian entrainment, glutamatergic/cholinergic synapses, calcium signaling, oxytocin, and retrograde endocannabinoid signaling as mechanisms by which PDE11A deletion protects against ARCD. Together, these data suggest that PDE11A4 proteinopathies acutely impair signaling in the aged brain and contribute to ARCD of social memories.
© 2022 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer's disease; COS-1; HEK293T; HT-22; STFP; TBI; age-related cognitive impairment; hippocampus; learning; memory; phosphodiesterase; proteopathy

Mesh:

Substances:

Year:  2022        PMID: 36073342      PMCID: PMC9577960          DOI: 10.1111/acel.13687

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   11.005


  98 in total

Review 1.  Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown.

Authors:  Miles D Houslay
Journal:  Trends Biochem Sci       Date:  2009-10-26       Impact factor: 13.807

2.  Interplay of palmitoylation and phosphorylation in the trafficking and localization of phosphodiesterase 10A: implications for the treatment of schizophrenia.

Authors:  Erik I Charych; Li-Xin Jiang; Frederick Lo; Kelly Sullivan; Nicholas J Brandon
Journal:  J Neurosci       Date:  2010-07-07       Impact factor: 6.167

3.  Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes.

Authors:  Michele P Kelly; Sheree F Logue; Julie Brennan; Jonathon P Day; Subha Lakkaraju; Lixin Jiang; Xiaotian Zhong; May Tam; Stacey J Sukoff Rizzo; Brian J Platt; Jason M Dwyer; Sarah Neal; Virginia L Pulito; Michael J Agostino; Steven M Grauer; Rachel L Navarra; Cody Kelley; Thomas A Comery; Richard J Murrills; Miles D Houslay; Nicholas J Brandon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

4.  Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model.

Authors:  Lourdes Orejana; Lucía Barros-Miñones; Joaquín Jordán; Elena Puerta; Norberto Aguirre
Journal:  Neurobiol Aging       Date:  2011-05-04       Impact factor: 4.673

5.  Age-related changes in the NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis.

Authors:  F Vallebuona; M Raiteri
Journal:  Eur J Neurosci       Date:  1995-04-01       Impact factor: 3.386

6.  Quantitative EEG of Rapid-Eye-Movement Sleep: A Marker of Amnestic Mild Cognitive Impairment.

Authors:  Pauline Brayet; Dominique Petit; Birgit Frauscher; Jean-François Gagnon; Nadia Gosselin; Katia Gagnon; Isabelle Rouleau; Jacques Montplaisir
Journal:  Clin EEG Neurosci       Date:  2015-08-30       Impact factor: 1.843

7.  Sildenafil accelerates reentrainment of circadian rhythms after advancing light schedules.

Authors:  Patricia V Agostino; Santiago A Plano; Diego A Golombek
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-22       Impact factor: 11.205

8.  Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model.

Authors:  Daniela Puzzo; Agnieszka Staniszewski; Shi Xian Deng; Lucia Privitera; Elena Leznik; Shumin Liu; Hong Zhang; Yan Feng; Agostino Palmeri; Donald W Landry; Ottavio Arancio
Journal:  J Neurosci       Date:  2009-06-24       Impact factor: 6.167

9.  Major depressive disorder and measures of cellular aging: an integrative review.

Authors:  Patricia Anne Kinser; Debra E Lyon
Journal:  Nurs Res Pract       Date:  2013-04-14

10.  Medial temporal lobe contributions to intra-item associative recognition memory in the aging brain.

Authors:  Marshall Axel Dalton; Sicong Tu; Michael Hornberger; John Russel Hodges; Olivier Piguet
Journal:  Front Behav Neurosci       Date:  2014-01-02       Impact factor: 3.558

View more
  1 in total

1.  Conserved age-related increases in hippocampal PDE11A4 cause unexpected proteinopathies and cognitive decline of social associative memories.

Authors:  Katy Pilarzyk; Latarsha Porcher; William R Capell; Steven D Burbano; Jeff Davis; Janet L Fisher; Nicole Gorny; Siena Petrolle; Michy P Kelly
Journal:  Aging Cell       Date:  2022-09-08       Impact factor: 11.005

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.